74 related articles for article (PubMed ID: 1810747)
1. The haematology of Plasmodium vivax before and after chloroquine and primaquine treatment in north Madras area.
Kumaresan PR; Selvam R
Indian J Malariol; 1991 Jun; 28(2):115-20. PubMed ID: 1810747
[TBL] [Abstract][Full Text] [Related]
2. Biochemical alterations in Plasmodium vivax-infected malarial patients before and after radical treatment.
Selvam R; Mathews ST
Indian J Malariol; 1992 Jun; 29(2):103-11. PubMed ID: 1459303
[TBL] [Abstract][Full Text] [Related]
3. Effect of radical treatment on erythrocyte lipid peroxidation in Plasmodium vivax-infected malaria patients.
Mathews ST; Selvam R
Biochem Int; 1991 Sep; 25(2):211-20. PubMed ID: 1789788
[TBL] [Abstract][Full Text] [Related]
4. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine sensitivity of Plasmodium vivax in Thailand.
Looareesuwan S; Wilairatana P; Krudsood S; Treeprasertsuk S; Singhasivanon P; Bussaratid V; Chokjindachai W; Viriyavejakul P; Chalermrut K; Walsh D S; White J
Ann Trop Med Parasitol; 1999 Apr; 93(3):225-30. PubMed ID: 10562823
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.
Dunne MW; Singh N; Shukla M; Valecha N; Bhattacharyya PC; Patel K; Mohapatra MK; Lakhani J; Devi CU; Adak T; Dev V; Yadav RS; Lele C; Patki K
Am J Trop Med Hyg; 2005 Dec; 73(6):1108-11. PubMed ID: 16354821
[TBL] [Abstract][Full Text] [Related]
7. [Hematologic variations in patient with malaria caused by Plasmodium vivax before, during and after treatment].
González B; Rodulfo H; De Donato M; Berrizbeitia M; Gómez C; González L
Invest Clin; 2009 Jun; 50(2):187-201. PubMed ID: 19662814
[TBL] [Abstract][Full Text] [Related]
8. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat.
Srivastava HC; Sharma SK; Bhatt RM; Sharma VP
Indian J Malariol; 1996 Dec; 33(4):173-9. PubMed ID: 9125831
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
11. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.
Dao NV; Cuong BT; Ngoa ND; Thuy le TT; The ND; Duy DN; Dai B; Thanh NX; Chavchich M; Rieckmann KH; Edstein MD
Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):534-9. PubMed ID: 17368694
[TBL] [Abstract][Full Text] [Related]
12. Alteration of platelet counts and lipid profiles after treatment of acute Plasmodium vivax.
Kim JS; Oh JS; Chang EA; Bae SY; Nam DH; Lee CH; Yang JH; Lee CK; Lee WJ; Kim HC; Klein TA; Lim CS; Kim YK
Acta Trop; 2008 Apr; 106(1):39-43. PubMed ID: 18304498
[TBL] [Abstract][Full Text] [Related]
13. Neglect of Plasmodium vivax malaria.
Baird JK
Trends Parasitol; 2007 Nov; 23(11):533-9. PubMed ID: 17933585
[TBL] [Abstract][Full Text] [Related]
14. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic failure wtih chloroquine and primaquine in malaria by Plasmodium vivax].
Ocampo A; García-Bujalance S; Ladrón de Guevara C
Enferm Infecc Microbiol Clin; 1998 Dec; 16(10):490-1. PubMed ID: 9919001
[No Abstract] [Full Text] [Related]
16. Poor response to primaquine in two cases of Plasmodium vivax malaria from Guatemala.
Gascon J; Gomez Arce JE; Menendez C; Valls ME; Corachán M
Trop Geogr Med; 1994; 46(1):32-3. PubMed ID: 8165734
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
Hamedi Y; Safa O; Zare S; Tan-ariya P; Kojima S; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):570-4. PubMed ID: 15689068
[TBL] [Abstract][Full Text] [Related]
18. Paucity of Plasmodium vivax mature schizonts in peripheral blood is associated with their increased cytoadhesive potential.
Lopes SC; Albrecht L; Carvalho BO; Siqueira AM; Thomson-Luque R; Nogueira PA; Fernandez-Becerra C; Del Portillo HA; Russell BM; Rénia L; Lacerda MV; Costa FT
J Infect Dis; 2014 May; 209(9):1403-7. PubMed ID: 24415786
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers.
Soto J; Toledo J; Rodriquez M; Sanchez J; Herrera R; Padilla J; Berman J
Clin Infect Dis; 1999 Jul; 29(1):199-201. PubMed ID: 10433587
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and antioxidant defence mechanism in Plasmodium vivax malaria before and after chloroquine treatment.
Sarin K; Kumar A; Prakash A; Sharma A
Indian J Malariol; 1993 Sep; 30(3):127-33. PubMed ID: 8131881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
